Anzeige
Mehr »
Samstag, 07.02.2026 - Börsentäglich über 12.000 News
Der Shakeout: Silber hat genau das getan, was echte Bullenmärkte immer tun - es hat die Touristen abgeschüttelt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Seeking Alpha

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrAdaptive Biotechnologies targets 30%+ clonoSEQ test volume growth in 2026 while expanding margins and data partnerships
FrNewell Brands outlines 2026 EPS guidance of $0.54-$0.60 and targets operating margin expansion amid productivity plan
FrCanopy Growth signals positive adjusted EBITDA in fiscal 2027 amid MTL acquisition and expanding European focus
FrAGC Inc. GAAP EPS of ¥325.67, revenue of ¥2058.8B
FrCompass said to have lost bid to halt part of Zillow's listing ban policy
FrDynatrace Q3 2026 Earnings Preview
FrCoty outlines targeted turnaround in Consumer Beauty through streamlined innovation and SKU focus
FrCleveland-Cliffs Q4 2025 Earnings Preview
FrBecton, Dickinson Q1 2026 Earnings Preview
FrFinecoBank Banca Fineco S.p.A. reports FY 2025 results
FrApollo Global Management Q4 2025 Earnings Preview
FrPepsiCo extends rally for a seventh straight session
FrPowerFleet Q3 2026 Earnings Preview
FrTPG to acquire majority stake in Sabre Industries from Blackstone
FrSilver's 'gamma squeezes' are over for now - analyst
FrCrypto-linked stocks rebound as bitcoin, ether rout ease
FrKomercní banka, a.s. reports Q4 2025 results
FrRXO outlines $5M-$12M Q1 2026 EBITDA outlook as cost actions and AI investments continue
FrValmet Oyj GAAP EPS of €1.52, revenue of €5.2B
FrGSK wins EU nod to expand Nucala for COPD
FrBanco de Sabadell, S.A. reports Q4 2025 results
FrNvidia leads chip stocks higher as broader market gains after software sell-off
FrI3 Verticals targets double-digit recurring revenue growth for FY 2026 as SaaS momentum accelerates
FrStrattec outlines $3.4M annualized savings from restructuring while advancing gross margin goals
FrUK regulator warns of rare vision loss risk with Novo's Ozempic, Wegovy